Evaluating quality of life after hyperbaric oxygen therapy for long COVID patients
Quality of Life After Hyperbaric Oxygen Therapy in Post-COVID Patients
This study is testing if hyperbaric oxygen therapy can improve the quality of life for long COVID patients, especially those with cognitive issues, one year after treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hyperbaar Geneeskundig Centrum Rijswijk Academic / other |
| Locations | 6 sites (Hoogeveen, Drenthe and 5 other locations) |
| Trial ID | NCT06159309 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the quality of life in patients suffering from long COVID, particularly those experiencing cognitive symptoms, one year after receiving hyperbaric oxygen therapy (HBOT). It will collect data through questionnaires and medical consultations at baseline and during treatment sessions, as well as follow-ups at 3 and 12 months post-treatment. The study will also evaluate the patients' return to work status and monitor any side effects or changes in medication throughout the treatment process. An interim analysis will be conducted after 6 months to determine the continuation or cessation of therapy based on patient improvement metrics.
Who should consider this trial
Good fit: Ideal candidates are long COVID patients experiencing cognitive symptoms for more than three months who are referred for hyperbaric oxygen therapy.
Not a fit: Patients who cannot complete questionnaires or do not understand the Dutch language may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the effectiveness of hyperbaric oxygen therapy in improving the quality of life for long COVID patients.
How similar studies have performed: Previous studies have shown promising results for hyperbaric oxygen therapy in improving quality of life for post-COVID patients, but long-term outcomes remain largely untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Long COVID patients who are reffered for treatment with hyperbaric oxygen therapy * Patients are suffering from cognitive symptoms for \>3 months after Covid infection Exclusion Criteria: * Patients who are not able to fill in questionnaires and informed consent. * Patients who can't read or do not understand the Dutch language
Where this trial is running
Hoogeveen, Drenthe and 5 other locations
- DVK Hogeveen — Hoogeveen, Drenthe, Netherlands (Recruiting)
- DVK Geldrop — Geldrop, Noord-Brabant, Netherlands (Recruiting)
- DVK Waalwijk — Waalwijk, Noord-Brabant, Netherlands (Recruiting)
- HGC Rijswijk — Rijswijk, South-Holland, Netherlands (Recruiting)
- DVK Rotterdam — Rotterdam, South-Holland, Netherlands (Recruiting)
- DVK Amersfoort — Amersfoort, Utrecht, Netherlands (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.